Page last updated: 2024-08-17

tributyrin and cyclin d1

tributyrin has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dabrowska, A; Feleszko, W; Giermasz, A; Gołab, J; Jakóbisiak, M; Jalili, A; Kozłowska, E; Maj, M; Makowski, M; Nowis, D; Wójcik, C1

Other Studies

1 other study(ies) available for tributyrin and cyclin d1

ArticleYear
Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice.
    International journal of cancer, 2002, Feb-20, Volume: 97, Issue:6

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Lewis Lung; Cell Cycle; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Synergism; Drug Therapy, Combination; Female; Flow Cytometry; Formazans; Lovastatin; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Tetrazolium Salts; Triglycerides; Tumor Suppressor Protein p53

2002